ArticleOncology letters2017

Novel homobarringtonie-containing therapy for the treatment of patients with primary acute myeloid leukemia that are resistant to conventional therapy.

Jingsong He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.